|
RAPH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.12539999541639E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.48519999970875E-07 |
| Normal-vs-Stage2 |
2.45300000001336E-06 |
| Normal-vs-Stage3 |
4.91410001579595E-09 |
| Normal-vs-Stage4 |
1.390060E-04 |
| Stage1-vs-Stage2 |
6.437200E-01 |
| Stage1-vs-Stage3 |
1.424420E-01 |
| Stage1-vs-Stage4 |
4.554400E-01 |
| Stage2-vs-Stage3 |
4.193000E-01 |
| Stage2-vs-Stage4 |
6.855200E-01 |
| Stage3-vs-Stage4 |
8.746200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95129468139044E-11 |
| Normal-vs-AfricanAmerican |
1.959300E-04 |
| Normal-vs-Asian |
1.62140000314892E-08 |
| Caucasian-vs-AfricanAmerican |
1.847590E-01 |
| Caucasian-vs-Asian |
1.788240E-01 |
| AfricanAmerican-vs-Asian |
4.466000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62558855265615E-12 |
| Normal-vs-Female |
4.696000E-03 |
| Male-vs-Female |
1.878250E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.221500E-04 |
| Normal-vs-Extreme_Weight |
1.05660002969188E-09 |
| Normal-vs-Obese |
1.047610E-04 |
| Normal-vs-Extreme_Obese |
9.95539994885775E-09 |
| Normal_Weight-vs-Extreme_Weight |
2.439200E-01 |
| Normal_Weight-vs-Obese |
6.238200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.515600E-01 |
| Extreme_Weight-vs-Obese |
2.348200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.138600E-01 |
| Obese-vs-Extreme_Obese |
1.698460E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.127400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.30439999998811E-06 |
| Normal-vs-Age(61-80Yrs) |
3.5260683262095E-13 |
| Normal-vs-Age(81-100Yrs) |
1.36480000001438E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.930200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.275820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.374000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.045570E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.844470E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.801000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.58329954386738E-10 |
| Normal-VS-Type2 PRCC |
1.42390000013037E-07 |
| Normal-VS-KIRP CIMP |
1.178350E-01 |
| Normal-VS-Unclassified PRCC |
8.412100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.937800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.834300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.040600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.294200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.209190E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.151400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.00660035862177E-10 |
| Normal-vs-N1 |
2.15679999999718E-05 |
| Normal-vs-N2 |
1.446630E-01 |
| N0-vs-N1 |
1.367560E-02 |
| N0-vs-N2 |
3.501700E-03 |
| N1-vs-N2 |
3.774600E-01 |
|
|
